| C025086 | 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid | "ALOX5 protein results in increased metabolism of 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid" | 7929400 |
| C025086 | 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid | "[ALOX5 protein results in increased metabolism of 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid] which results in increased abundance of Leukotriene B4 analog" | 7929400 |
| C025984 | 15-hydroxy-5,8,11,13-eicosatetraenoic acid | "[benoxaprofen results in decreased activity of ALOX5 protein] which results in increased abundance of 15-hydroxy-5,8,11,13-eicosatetraenoic acid" | 2849922 |
| C025984 | 15-hydroxy-5,8,11,13-eicosatetraenoic acid | "[Masoprocol results in decreased activity of ALOX5 protein] which results in increased abundance of 15-hydroxy-5,8,11,13-eicosatetraenoic acid" | 2849922 |
| C025984 | 15-hydroxy-5,8,11,13-eicosatetraenoic acid | "[RS 43179 results in decreased activity of ALOX5 protein] which results in increased abundance of 15-hydroxy-5,8,11,13-eicosatetraenoic acid" | 2849922 |
| C025984 | 15-hydroxy-5,8,11,13-eicosatetraenoic acid | "[tenidap results in decreased activity of ALOX5 protein] which results in increased abundance of 15-hydroxy-5,8,11,13-eicosatetraenoic acid" | 2849922 |
| C025984 | 15-hydroxy-5,8,11,13-eicosatetraenoic acid | "15-hydroxy-5,8,11,13-eicosatetraenoic acid results in decreased activity of ALOX5 protein" | 2849922 |
| C062894 | 17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid | "17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid results in decreased expression of ALOX5 protein" | 17056761 |
| C520323 | 1-oleoyl-2-acetoyl-sn-glycerol | 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [1-Butanol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]] | 18218859 |
| C520323 | 1-oleoyl-2-acetoyl-sn-glycerol | 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [1-Butanol inhibits the reaction [Thapsigargin results in increased activity of and results in increased localization of ALOX5 protein]] | 18218859 |
| C520323 | 1-oleoyl-2-acetoyl-sn-glycerol | 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]] | 18218859 |
| C520323 | 1-oleoyl-2-acetoyl-sn-glycerol | 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [Propranolol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]] | 18218859 |
| C400184 | 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine | 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphorylcholine results in increased expression of ALOX5 mRNA | 16386258 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ALOX5 mRNA" | 25614096 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ALOX5 mRNA" | 23146750 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acrolein results in increased expression of ALOX5 protein] | 20153347 |
| C036837 | 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone | "2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone results in decreased activity of ALOX5 protein" | 23238474|2724698 |
| C036837 | 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone | "2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone results in decreased activity of ALOX5 protein" | 2724698 |
| C036837 | 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone | "2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone results in decreased activity of ALOX5 protein" | 2724698 |
| C036837 | 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone | "2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone results in decreased activity of ALOX5 protein" | 25432964|7812673 |
| C036837 | 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone | "2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone results in decreased activity of ALOX5 protein" | 2724698 |
| C036837 | 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone | "2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone results in decreased activity of ALOX5 protein" | 2724698 |
| C036837 | 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone | "2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone results in decreased activity of ALOX5 protein" | 17925309 |
| C548544 | 2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid | "2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid results in decreased activity of ALOX5 protein" | 19934399 |
| C558746 | 2-(4-chlorophenyl)-5-(4-methoxybenzylidene)-5H-thiazol-4-one | 2-(4-chlorophenyl)-5-(4-methoxybenzylidene)-5H-thiazol-4-one results in decreased activity of ALOX5 protein | 21341744 |
| C063918 | 2-(4-hydroxy-3,5-dimethylphenyl)-5-methoxy-3-methylindole | "2-(4-hydroxy-3,5-dimethylphenyl)-5-methoxy-3-methylindole results in decreased activity of ALOX5 protein" | 7812673 |
| C079315 | 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid | 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid results in decreased activity of ALOX5 protein | 12954791 |
| C079315 | 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid | 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of ALOX5 protein] | 16033810 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of ALOX5 mRNA" | 20816883 |
| C031278 | 2-chloroethyl ethyl sulfide | 2-chloroethyl ethyl sulfide results in increased expression of ALOX5 mRNA | 20840853 |
| C031278 | 2-chloroethyl ethyl sulfide | 2-chloroethyl ethyl sulfide results in increased expression of ALOX5 mRNA | 20382172 |
| C031278 | 2-chloroethyl ethyl sulfide | 2-chloroethyl ethyl sulfide results in increased expression of ALOX5 protein | 20382172 |
| C031278 | 2-chloroethyl ethyl sulfide | SB 203580 inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of ALOX5 mRNA] | 20382172 |
| C572491 | 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol | 3-(2-hydroxy-4-(2-methylnonan-2-yl)phenyl)cyclohexan-1-ol results in increased expression of ALOX5 protein | 26194647 |
| C472791 | 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid | 3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of ALOX5 mRNA | 16788091 |
| C550724 | 4-(3-(4-(1-methyl-1H-pyrazol-5-yl)phenylthio)phenyl)-tetrahydro-2H-pyran-4-carboxamide | 4-(3-(4-(1-methyl-1H-pyrazol-5-yl)phenylthio)phenyl)-tetrahydro-2H-pyran-4-carboxamide results in decreased activity of ALOX5 protein | 21739938 |
| C119130 | 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | ALOX5 protein affects the reaction [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide affects the expression of CCL2 mRNA] | 17766677 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALOX5 mRNA" | 27188386 |
| C027576 | 4-hydroxy-2-nonenal | ALOX5 mutant form inhibits the reaction [4-hydroxy-2-nonenal results in increased expression of MMP9 protein] | 19837106 |
| C012358 | 4-hydroxycyclophosphamide | [afimoxifene co-treated with 4-hydroxycyclophosphamide] affects the expression of ALOX5 mRNA | 25833159 |
| C116824 | 5-((1,5-bis(4-methoxyphenyl)pyrazol-3-yl)dimethoxymethyl)-2-chlorobenzamide | "5-((1,5-bis(4-methoxyphenyl)pyrazol-3-yl)dimethoxymethyl)-2-chlorobenzamide results in decreased activity of ALOX5 protein" | 9831321 |
| C116824 | 5-((1,5-bis(4-methoxyphenyl)pyrazol-3-yl)dimethoxymethyl)-2-chlorobenzamide | "[5-((1,5-bis(4-methoxyphenyl)pyrazol-3-yl)dimethoxymethyl)-2-chlorobenzamide results in decreased activity of ALOX5 protein] which results in decreased abundance of Eicosanoids" | 9831321 |
| C058691 | 5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-phosphate | "5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-phosphate analog results in decreased activity of ALOX5 protein" | 2724698 |
| C058691 | 5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-phosphate | "5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-phosphate analog results in decreased activity of ALOX5 protein" | 2724698 |
| C058691 | 5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-phosphate | "5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-phosphate analog results in decreased activity of ALOX5 protein" | 2724698 |
| C058691 | 5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-phosphate | "5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-phosphate analog results in decreased activity of ALOX5 protein" | 2724698 |
| C058691 | 5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-phosphate | "5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-phosphate analog results in decreased activity of ALOX5 protein" | 2724698 |
| C022022 | 5-hydroxy-6,8,11,14-eicosatetraenoic acid | "ALOX5 protein results in increased chemical synthesis of 5-hydroxy-6,8,11,14-eicosatetraenoic acid" | 18295198 |
| C047651 | 5-hydroxyeicosatetraenoic acid lactone | 5-hydroxyeicosatetraenoic acid lactone results in decreased activity of ALOX5 protein | 12629151 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALOX5 mRNA" | 27188386 |
| C068314 | 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one | 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]] | 18218859 |
| C068314 | 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one | 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] | 18218859 |
| C082739 | A 78773 | [[A 78773 co-treated with Calcimycin] results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4 | 11529688 |
| C082739 | A 78773 | A 78773 results in decreased activity of ALOX5 protein | 11529688 |
| C496492 | abrine | abrine results in increased expression of ALOX5 mRNA | 22595364 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of ALOX5 mRNA | 17562736 |
| C045543 | acetone phenylhydrazone | acetone phenylhydrazone results in decreased activity of ALOX5 protein | 3928952 |
| D000171 | Acrolein | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acrolein results in increased expression of ALOX5 protein] | 20153347 |
| D000171 | Acrolein | Acrolein results in increased activity of ALOX5 protein | 20153347 |
| D000171 | Acrolein | Acrolein results in increased expression of ALOX5 mRNA | 20153347 |
| D000171 | Acrolein | Acrolein results in increased expression of ALOX5 protein | 20153347 |
| D000171 | Acrolein | tyrphostin AG 1478 inhibits the reaction [Acrolein results in increased expression of ALOX5 protein] | 20153347 |
| D020106 | Acrylamide | Acrylamide results in decreased expression of ALOX5 mRNA | 28959563 |
| D000227 | Adenine Nucleotides | Adenine Nucleotides binds to ALOX5 protein | 7577949 |
| C016601 | afimoxifene | [afimoxifene co-treated with 4-hydroxycyclophosphamide] affects the expression of ALOX5 mRNA | 25833159 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in increased expression of ALOX5 mRNA | 22100608 |
| C412373 | AG 1879 | AG 1879 inhibits the reaction [Nicotine results in increased expression of ALOX5 protein] | 14569062 |
| C412373 | AG 1879 | [tyrphostin AG 1478 co-treated with AG 1879] inhibits the reaction [Nicotine results in increased expression of ALOX5 protein] | 14569062 |
| D000447 | Aldehydes | Aldehydes results in increased expression of ALOX5 mRNA | 25014914 |
| C049740 | alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol | alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol results in decreased activity of ALOX5 protein | 12629151 |
| C049740 | alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol | alpha-pentyl-3-(2-quinolinylmethoxy)benzenemethanol results in decreased activity of ALOX5 protein | 18927292 |
| D000535 | Aluminum | Aluminum results in increased expression of ALOX5 mRNA | 27368151 |
| D000535 | Aluminum | Aluminum results in increased expression of ALOX5 protein | 27368151 |
| D000535 | Aluminum | caffeic acid inhibits the reaction [Aluminum results in increased expression of ALOX5 mRNA] | 27368151 |
| D000535 | Aluminum | caffeic acid inhibits the reaction [Aluminum results in increased expression of ALOX5 protein] | 27368151 |
| C010845 | aluminum chloride | aluminum chloride results in increased expression of ALOX5 mRNA | 18482095 |
| C010845 | aluminum chloride | aluminum chloride results in increased expression of ALOX5 protein | 18482095 |
| C010845 | aluminum chloride | caffeic acid inhibits the reaction [aluminum chloride results in increased expression of ALOX5 mRNA] | 18482095 |
| C010845 | aluminum chloride | caffeic acid inhibits the reaction [aluminum chloride results in increased expression of ALOX5 protein] | 18482095 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of ALOX5 mRNA | 16483693 |
| D018501 | Antirheumatic Agents | Antirheumatic Agents results in decreased expression of ALOX5 mRNA | 24449571 |
| D016718 | Arachidonic Acid | ALOX5 protein results in increased metabolism of Arachidonic Acid | 18295198 |
| D016718 | Arachidonic Acid | Arachidonic Acid inhibits the reaction [L 708714 binds to ALOX5 protein] | 7577949 |
| D016718 | Arachidonic Acid | CJ 13610 inhibits the reaction [ALOX5 protein results in increased metabolism of Arachidonic Acid] | 18295198 |
| D016718 | Arachidonic Acid | [sodium arsenite co-treated with Platelet Activating Factor co-treated with Arachidonic Acid] results in increased phosphorylation of and results in increased activity of ALOX5 protein | 10779545 |
| D016718 | Arachidonic Acid | [Sorbitol co-treated with Calcimycin co-treated with Arachidonic Acid] affects the localization of ALOX5 protein | 11698504 |
| D016718 | Arachidonic Acid | zileuton inhibits the reaction [ALOX5 protein results in increased metabolism of Arachidonic Acid] | 18295198 |
| D016718 | Arachidonic Acid | [zileuton results in decreased activity of ALOX5 protein] which affects the abundance of Arachidonic Acid | 9495842 |
| D016718 | Arachidonic Acid | [zileuton results in decreased activity of ALOX5 protein] which results in decreased susceptibility to Arachidonic Acid | 7592874 |
| D016718 | Arachidonic Acid | ALOX5 protein affects the metabolism of Arachidonic Acid | 22613217 |
| D016718 | Arachidonic Acid | ALOX5 protein results in increased metabolism of Arachidonic Acid | 18951527 |
| D016718 | Arachidonic Acid | [Diamide co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D016718 | Arachidonic Acid | [Hydrogen Peroxide co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D016718 | Arachidonic Acid | [oxophenylarsine co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D016718 | Arachidonic Acid | [Potassium Chloride co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D016718 | Arachidonic Acid | SB 203580 inhibits the reaction [[Hydrogen Peroxide co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein] | 11698504 |
| D016718 | Arachidonic Acid | SB 203580 inhibits the reaction [[Sodium Chloride co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein] | 11698504 |
| D016718 | Arachidonic Acid | [sodium arsenite co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D016718 | Arachidonic Acid | [Sodium Chloride co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D016718 | Arachidonic Acid | [Sorbitol co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D016718 | Arachidonic Acid | [Sorbitol co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D016718 | Arachidonic Acid | Thapsigargin promotes the reaction [[Sorbitol co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein] | 11698504 |
| D016718 | Arachidonic Acid | [TNF protein co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D016718 | Arachidonic Acid | [Vanadates co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D001151 | Arsenic | Arsenic affects the expression of ALOX5 mRNA | 18414638 |
| C517830 | arzanol | arzanol results in decreased activity of ALOX5 protein | 20933508 |
| C038044 | baicalin | baicalin inhibits the reaction [Hydrogen Peroxide affects the localization of and results in increased activity of ALOX5 protein] | 20139896 |
| C011677 | benoxaprofen | benoxaprofen results in decreased activity of ALOX5 protein | 2849922|3020588 |
| C011677 | benoxaprofen | [benoxaprofen results in decreased activity of ALOX5 protein] which results in decreased chemical synthesis of Leukotriene B4 | 2849922 |
| C011677 | benoxaprofen | "[benoxaprofen results in decreased activity of ALOX5 protein] which results in increased abundance of 15-hydroxy-5,8,11,13-eicosatetraenoic acid" | 2849922 |
| C011677 | benoxaprofen | benoxaprofen results in decreased activity of ALOX5 protein | 2724698|3928952 |
| C011677 | benoxaprofen | benoxaprofen results in decreased activity of ALOX5 protein | 6131964 |
| C030935 | benz(a)anthracene | benz(a)anthracene results in increased expression of ALOX5 mRNA | 26377693 |
| D001554 | Benzene | ALOX5 gene SNP affects the susceptibility to Benzene | 21540635 |
| C006703 | benzo(b)fluoranthene | benzo(b)fluoranthene results in increased expression of ALOX5 mRNA | 26377693 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of ALOX5 mRNA | 19737606 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene promotes the reaction [Calcitriol results in increased expression of ALOX5 mRNA] | 19244278 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene promotes the reaction [AHR protein binds to ALOX5 promoter] | 19654925 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of ALOX5 mRNA | 22228805 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of ALOX5 mRNA | 19770486|2373587 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of ALOX5 mRNA | 22300585 |
| D004958 | Estradiol | Estradiol results in decreased expression of ALOX5 protein | 17143502 |
| D004958 | Estradiol | Estradiol results in increased expression of ALOX5 mRNA | 19484750 |
| C070515 | bisindolylmaleimide I | bisindolylmaleimide I inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein] | 10779545 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of ALOX5 gene | 28505145 |
| C500927 | bolinaquinone | bolinaquinone inhibits the reaction [Calcimycin results in increased activity of ALOX5 protein] | 12604694 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] | 18218859 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [Thapsigargin results in increased activity of and results in increased localization of ALOX5 protein] | 18218859 |
| D020001 | 1-Butanol | 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [1-Butanol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]] | 18218859 |
| D020001 | 1-Butanol | 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [1-Butanol inhibits the reaction [Thapsigargin results in increased activity of and results in increased localization of ALOX5 protein]] | 18218859 |
| D002084 | Butylated Hydroxytoluene | Butylated Hydroxytoluene affects the localization of ALOX5 protein | 12376474 |
| D002084 | Butylated Hydroxytoluene | Celecoxib inhibits the reaction [Butylated Hydroxytoluene affects the localization of ALOX5 protein] | 12376474 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased expression of ALOX5 mRNA | 15336504 |
| C018475 | butyraldehyde | butyraldehyde results in increased expression of ALOX5 mRNA | 26079696 |
| C080871 | BW B70C | BW B70C results in decreased activity of ALOX5 protein | 23238474 |
| D002104 | Cadmium | Cadmium results in increased expression of ALOX5 protein | 26424772 |
| D002104 | Cadmium | flavocoxid inhibits the reaction [Cadmium results in increased expression of ALOX5 protein] | 26424772 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of ALOX5 mRNA | 23741332 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in increased expression of ALOX5 protein | 26424772 |
| D019256 | Cadmium Chloride | flavocoxid inhibits the reaction [Cadmium Chloride results in increased expression of ALOX5 protein] | 26424772 |
| C040048 | caffeic acid | caffeic acid inhibits the reaction [aluminum chloride results in increased expression of ALOX5 mRNA] | 18482095 |
| C040048 | caffeic acid | caffeic acid inhibits the reaction [aluminum chloride results in increased expression of ALOX5 protein] | 18482095 |
| C040048 | caffeic acid | caffeic acid inhibits the reaction [Aluminum results in increased expression of ALOX5 mRNA] | 27368151 |
| C040048 | caffeic acid | caffeic acid inhibits the reaction [Aluminum results in increased expression of ALOX5 protein] | 27368151 |
| C040048 | caffeic acid | caffeic acid inhibits the reaction [Hydrogen Peroxide affects the localization of ALOX5 protein] | 18951527 |
| C040048 | caffeic acid | caffeic acid inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein] | 18951527 |
| C040048 | caffeic acid | caffeic acid results in decreased activity of ALOX5 protein | 18482095|1895152 |
| D000001 | Calcimycin | 1-Butanol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] | 18218859 |
| D000001 | Calcimycin | 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [1-Butanol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]] | 18218859 |
| D000001 | Calcimycin | 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]] | 18218859 |
| D000001 | Calcimycin | 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [Propranolol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]] | 18218859 |
| D000001 | Calcimycin | 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] | 18218859 |
| D000001 | Calcimycin | bisindolylmaleimide I inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein] | 10779545 |
| D000001 | Calcimycin | bolinaquinone inhibits the reaction [Calcimycin results in increased activity of ALOX5 protein] | 12604694 |
| D000001 | Calcimycin | Calcimycin results in increased activity of ALOX5 protein | 11698504|1847547 |
| D000001 | Calcimycin | Calcimycin results in increased activity of and results in increased localization of ALOX5 protein | 18218859 |
| D000001 | Calcimycin | Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein | 10779545 |
| D000001 | Calcimycin | Propranolol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] | 18218859 |
| D000001 | Calcimycin | SB 203580 inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein] | 10779545 |
| D000001 | Calcimycin | [Sorbitol co-treated with Calcimycin co-treated with Arachidonic Acid] affects the localization of ALOX5 protein | 11698504 |
| D000001 | Calcimycin | tert-Butyl Alcohol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] | 18218859 |
| D000001 | Calcimycin | [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of ALOX5 protein | 11698504 |
| D000001 | Calcimycin | U 0126 inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein] | 10779545 |
| D000001 | Calcimycin | [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [Calcimycin results in increased abundance of Platelet Activating Factor] | 8387780 |
| D000001 | Calcimycin | [[A 78773 co-treated with Calcimycin] results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4 | 11529688 |
| D000001 | Calcimycin | Calcimycin results in increased activity of and results in increased localization of ALOX5 protein | 9445378 |
| D000001 | Calcimycin | [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] which results in increased abundance of Leukotriene B4 | 9445378 |
| D000001 | Calcimycin | [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] which results in increased abundance of Leukotriene C4 | 9445378 |
| D000001 | Calcimycin | Calcimycin results in increased expression of ALOX5 mRNA | 18083043 |
| D000001 | Calcimycin | Calcimycin results in increased expression of ALOX5 protein | 18083043 |
| D000001 | Calcimycin | Calcimycin results in increased localization of and results in increased activity of ALOX5 protein | 7665580 |
| D000001 | Calcimycin | CCL5 protein promotes the reaction [Calcimycin results in increased expression of ALOX5 mRNA] | 18083043 |
| D000001 | Calcimycin | CCL5 protein promotes the reaction [Calcimycin results in increased expression of ALOX5 protein] | 18083043 |
| D000001 | Calcimycin | [[CMI 392 co-treated with Calcimycin] results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4 | 11529688 |
| D000001 | Calcimycin | Dexamethasone inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein] | 18083043 |
| D000001 | Calcimycin | Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 mRNA] | 18083043 |
| D000001 | Calcimycin | Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein] | 18083043 |
| D000001 | Calcimycin | [[zileuton co-treated with Calcimycin] results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4 | 11529688 |
| D000001 | Calcimycin | [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [Calcimycin results in increased abundance of Leukotriene B4] | 18475545 |
| D000001 | Calcimycin | [Diamide co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D000001 | Calcimycin | [Hydrogen Peroxide co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D000001 | Calcimycin | [oxophenylarsine co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D000001 | Calcimycin | [Potassium Chloride co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D000001 | Calcimycin | SB 203580 inhibits the reaction [[Hydrogen Peroxide co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein] | 11698504 |
| D000001 | Calcimycin | SB 203580 inhibits the reaction [[Sodium Chloride co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein] | 11698504 |
| D000001 | Calcimycin | [sodium arsenite co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D000001 | Calcimycin | [Sodium Chloride co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D000001 | Calcimycin | [Sorbitol co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D000001 | Calcimycin | [TNF protein co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D000001 | Calcimycin | [Vanadates co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D002118 | Calcium | Calcium promotes the reaction [L 708714 binds to ALOX5 protein] | 7577949 |
| D002211 | Capsaicin | [Capsaicin co-treated with Curcumin] results in decreased activity of ALOX5 protein | 16956363 |
| D002211 | Capsaicin | Capsaicin results in decreased activity of ALOX5 protein | 16956363 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of ALOX5 protein | 25432964 |
| D002251 | Carbon Tetrachloride | PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of ALOX5 protein] | 25432964 |
| D002251 | Carbon Tetrachloride | SC 560 promotes the reaction [Carbon Tetrachloride results in increased expression of ALOX5 protein] | 25432964 |
| D002251 | Carbon Tetrachloride | 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of ALOX5 protein] | 16033810 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of ALOX5 protein | 16033810 |
| D000068579 | Celecoxib | Celecoxib inhibits the reaction [Butylated Hydroxytoluene affects the localization of ALOX5 protein] | 12376474 |
| D017332 | Cetirizine | Cetirizine analog results in decreased activity of ALOX5 protein | 15482930 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ALOX5 mRNA | 20938992 |
| C074702 | chromium hexavalent ion | chromium hexavalent ion affects the expression of ALOX5 mRNA | 28472532 |
| C496810 | CJ 13610 | CJ 13610 inhibits the reaction [ALOX5 protein results in increased metabolism of Arachidonic Acid] | 18295198 |
| C496810 | CJ 13610 | CJ 13610 results in decreased activity of ALOX5 protein | 18295198 |
| C496810 | CJ 13610 | CJ 13610 results in decreased activity of ALOX5 protein | 17766677 |
| C496810 | CJ 13610 | CJ 13610 results in decreased activity of ALOX5 protein | 18295198 |
| C112433 | CMI 392 | [[CMI 392 co-treated with Calcimycin] results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4 | 11529688 |
| C112433 | CMI 392 | CMI 392 results in decreased activity of ALOX5 protein | 11529688|9599246 |
| C423222 | cotylenin A | cotylenin A results in increased expression of ALOX5 mRNA | 16129123 |
| C030123 | coumarin | coumarin results in increased expression of ALOX5 mRNA | 18480146 |
| D003474 | Curcumin | [Capsaicin co-treated with Curcumin] results in decreased activity of ALOX5 protein | 16956363 |
| D003474 | Curcumin | Curcumin results in decreased activity of ALOX5 protein | 16956363 |
| D003474 | Curcumin | Curcumin results in decreased expression of ALOX5 | 18462866 |
| C109268 | darbufelone | darbufelone results in decreased activity of ALOX5 protein | 21341744 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein] | 18083043 |
| D003958 | Diamide | [Diamide co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in increased expression of ALOX5 mRNA | 27392435 |
| D002945 | Cisplatin | Cisplatin results in increased expression of ALOX5 mRNA | 27392435|2759478 |
| C036042 | dicyclohexyl phthalate | dicyclohexyl phthalate affects the expression of ALOX5 mRNA | 26924002 |
| D004026 | Dieldrin | Dieldrin results in decreased expression of ALOX5 mRNA | 28385952 |
| D004041 | Dietary Fats | [AGT protein affects the susceptibility to Dietary Fats] which affects the expression of ALOX5 mRNA | 26704350 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of ALOX5 mRNA | 25016146 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of ALOX5 mRNA | 24535843 |
| D015772 | 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine | "4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine results in decreased activity of ALOX5 protein" | 3020588 |
| D015772 | 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine | "4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine results in decreased activity of ALOX5 protein" | 3145369|7990266 |
| D015772 | 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine | "4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine results in decreased activity of ALOX5 protein" | 3928952 |
| D002117 | Calcitriol | Benzo(a)pyrene promotes the reaction [Calcitriol results in increased expression of ALOX5 mRNA] | 19244278 |
| D002117 | Calcitriol | Calcitriol analog results in increased activity of ALOX5 protein | 10799658 |
| D002117 | Calcitriol | Calcitriol results in increased expression of ALOX5 mRNA | 16002434|1612912 |
| C024629 | dimethyl phthalate | dimethyl phthalate results in decreased expression of ALOX5 mRNA | 26924002 |
| D004121 | Dimethyl Sulfoxide | "[OVAL protein co-treated with enterotoxin B, staphylococcal co-treated with Dimethyl Sulfoxide] results in increased expression of ALOX5 protein" | 23751068 |
| D004121 | Dimethyl Sulfoxide | "resveratrol inhibits the reaction [[OVAL protein co-treated with enterotoxin B, staphylococcal co-treated with Dimethyl Sulfoxide] results in increased expression of ALOX5 protein]" | 23751068 |
| D004121 | Dimethyl Sulfoxide | "Triamcinolone Acetonide inhibits the reaction [[OVAL protein co-treated with enterotoxin B, staphylococcal co-treated with Dimethyl Sulfoxide] results in increased expression of ALOX5 protein]" | 23751068 |
| C007488 | dinitrobenzenesulfonic acid | ALOX5 protein affects the reaction [dinitrobenzenesulfonic acid affects the localization of OCLN protein] | 16670640 |
| C007488 | dinitrobenzenesulfonic acid | ALOX5 protein affects the reaction [dinitrobenzenesulfonic acid affects the localization of TJP1 protein] | 16670640 |
| C007488 | dinitrobenzenesulfonic acid | ALOX5 protein affects the reaction [dinitrobenzenesulfonic acid results in increased activity of MPO protein] | 15821759 |
| C007488 | dinitrobenzenesulfonic acid | ALOX5 protein affects the reaction [dinitrobenzenesulfonic acid results in increased expression of ICAM1 protein] | 15821759 |
| C007488 | dinitrobenzenesulfonic acid | ALOX5 protein affects the reaction [dinitrobenzenesulfonic acid results in increased expression of SELE protein] | 15821759 |
| C007488 | dinitrobenzenesulfonic acid | ALOX5 protein affects the reaction [dinitrobenzenesulfonic acid results in increased expression of SELP protein] | 15821759 |
| C007488 | dinitrobenzenesulfonic acid | ALOX5 protein affects the reaction [dinitrobenzenesulfonic acid results in increased expression of VCAM1 protein] | 15821759 |
| C007488 | dinitrobenzenesulfonic acid | ALOX5 protein affects the susceptibility to dinitrobenzenesulfonic acid | 16670640 |
| C004848 | dithiol | dithiol results in decreased activity of ALOX5 protein | 3928952 |
| D004281 | Docosahexaenoic Acids | Docosahexaenoic Acids results in decreased expression of ALOX5 protein | 17056761 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in decreased activity of ALOX5 protein" | 19066064 |
| C083427 | (E)-3-((((6-(2-carboxyethenyl)-5-((8-(4-methoxyphenyl)octyl)oxy)-2-pyridinyl)methyl)thio)methyl)benzoic acid | (E)-3-((((6-(2-carboxyethenyl)-5-((8-(4-methoxyphenyl)octyl)oxy)-2-pyridinyl)methyl)thio)methyl)benzoic acid results in decreased activity of ALOX5 protein | 10477044 |
| C064507 | E 6080 | E 6080 results in decreased activity of ALOX5 protein | 7812673 |
| C042986 | ebselen | ebselen results in decreased activity of ALOX5 protein | 7590103 |
| C121361 | efletirizine | efletirizine analog results in decreased activity of ALOX5 protein | 15482930 |
| C025421 | eicosa-8,11,14-trien-5-ynoic acid | "eicosa-8,11,14-trien-5-ynoic acid results in decreased activity of ALOX5 protein" | 12582831 |
| D015777 | Eicosanoids | "[5-((1,5-bis(4-methoxyphenyl)pyrazol-3-yl)dimethoxymethyl)-2-chlorobenzamide results in decreased activity of ALOX5 protein] which results in decreased abundance of Eicosanoids" | 9831321 |
| D015777 | Eicosanoids | [zileuton results in decreased activity of ALOX5 protein] which results in decreased abundance of Eicosanoids | 9831321 |
| D004726 | Endosulfan | Endosulfan results in increased expression of ALOX5 mRNA | 26615145 |
| C031818 | enterotoxin B, staphylococcal | "[OVAL protein co-treated with enterotoxin B, staphylococcal co-treated with Dimethyl Sulfoxide] results in increased expression of ALOX5 protein" | 23751068 |
| C031818 | enterotoxin B, staphylococcal | "resveratrol inhibits the reaction [[OVAL protein co-treated with enterotoxin B, staphylococcal co-treated with Dimethyl Sulfoxide] results in increased expression of ALOX5 protein]" | 23751068 |
| C031818 | enterotoxin B, staphylococcal | "Triamcinolone Acetonide inhibits the reaction [[OVAL protein co-treated with enterotoxin B, staphylococcal co-treated with Dimethyl Sulfoxide] results in increased expression of ALOX5 protein]" | 23751068 |
| C118739 | entinostat | entinostat results in increased expression of ALOX5 mRNA | 27188386 |
| D000431 | Ethanol | Ethanol results in increased expression of ALOX5 mRNA | 28069986 |
| D005015 | Ethoxyquin | Ethoxyquin results in decreased activity of ALOX5 protein | 3928952 |
| C544478 | flavocoxid | flavocoxid inhibits the reaction [Cadmium Chloride results in increased expression of ALOX5 protein] | 26424772 |
| C544478 | flavocoxid | flavocoxid inhibits the reaction [Cadmium results in increased expression of ALOX5 protein] | 26424772 |
| D005419 | Flavonoids | Flavonoids results in increased expression of ALOX5 mRNA | 18035473 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ALOX5 mRNA | 20938992 |
| D009240 | N-Formylmethionine Leucyl-Phenylalanine | ALOX5 protein promotes the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased expression of SELP protein] | 11116075 |
| D009240 | N-Formylmethionine Leucyl-Phenylalanine | N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of ALOX5 protein | 10779545 |
| D009240 | N-Formylmethionine Leucyl-Phenylalanine | SB 203580 inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of ALOX5 protein] | 10779545 |
| D009240 | N-Formylmethionine Leucyl-Phenylalanine | [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Leukotriene C4] | 9495842 |
| C006312 | FPL 55712 | FPL 55712 results in decreased activity of ALOX5 protein | 2724698 |
| C006312 | FPL 55712 | FPL 55712 results in decreased activity of ALOX5 protein | 2724698 |
| C006312 | FPL 55712 | FPL 55712 results in decreased activity of ALOX5 protein | 2724698 |
| C006312 | FPL 55712 | FPL 55712 results in decreased activity of ALOX5 protein | 2724698 |
| C039281 | furan | furan results in increased expression of ALOX5 mRNA | 27387713 |
| C046905 | glucosamine 6-O-sulfate | glucosamine 6-O-sulfate inhibits the reaction [Lipopolysaccharides results in increased expression of ALOX5 mRNA] | 21877189 |
| D005947 | Glucose | caffeic acid inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein] | 18951527 |
| D005947 | Glucose | [Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein | 18951527 |
| D005947 | Glucose | phenylmethylpyrazolone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein] | 18951527 |
| D005947 | Glucose | SB 203580 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein] | 18951527 |
| D007975 | Leukotriene B4 | "ALOX5 protein promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased abundance of Leukotriene B4]" | 15501964 |
| D007975 | Leukotriene B4 | ALOX5 protein results in increased chemical synthesis of Leukotriene B4 | 18096136 |
| D007975 | Leukotriene B4 | ALOX5 protein results in increased secretion of Leukotriene B4 | 11325678 |
| D007975 | Leukotriene B4 | ALOX5 protein results in increased susceptibility to [Histamine results in increased abundance of Leukotriene B4] | 9609743 |
| D007975 | Leukotriene B4 | [benoxaprofen results in decreased activity of ALOX5 protein] which results in decreased chemical synthesis of Leukotriene B4 | 2849922 |
| D007975 | Leukotriene B4 | [Hydrogen Peroxide results in increased activity of ALOX5 protein] which results in increased chemical synthesis of Leukotriene B4 | 10491155 |
| D007975 | Leukotriene B4 | kaempferol inhibits the reaction [ALOX5 protein results in increased chemical synthesis of Leukotriene B4] | 18096136 |
| D007975 | Leukotriene B4 | Luteolin inhibits the reaction [ALOX5 protein results in increased chemical synthesis of Leukotriene B4] | 18096136 |
| D007975 | Leukotriene B4 | [Masoprocol results in decreased activity of ALOX5 protein] which results in decreased chemical synthesis of Leukotriene B4 | 2849922 |
| D007975 | Leukotriene B4 | quercetin 3-O-glucuronide inhibits the reaction [ALOX5 protein results in increased chemical synthesis of Leukotriene B4] | 18096136 |
| D007975 | Leukotriene B4 | quercetin 3'-sulfate inhibits the reaction [ALOX5 protein results in increased chemical synthesis of Leukotriene B4] | 18096136 |
| D007975 | Leukotriene B4 | Quercetin inhibits the reaction [ALOX5 protein results in increased chemical synthesis of Leukotriene B4] | 18096136 |
| D007975 | Leukotriene B4 | resveratrol inhibits the reaction [[Hydrogen Peroxide results in increased activity of ALOX5 protein] which results in increased chemical synthesis of Leukotriene B4] | 10491155 |
| D007975 | Leukotriene B4 | [RS 43179 results in decreased activity of ALOX5 protein] which results in decreased chemical synthesis of Leukotriene B4 | 2849922 |
| D007975 | Leukotriene B4 | [Tamoxifen results in increased expression of ALOX5 protein] which results in increased abundance of Leukotriene B4 | 9742967 |
| D007975 | Leukotriene B4 | [tenidap results in decreased activity of ALOX5 protein] which results in decreased chemical synthesis of Leukotriene B4 | 2849922 |
| D007975 | Leukotriene B4 | "zileuton inhibits the reaction [ALOX5 protein promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased abundance of Leukotriene B4]]" | 15501964 |
| D007975 | Leukotriene B4 | zileuton inhibits the reaction [ALOX5 protein results in increased susceptibility to [Histamine results in increased abundance of Leukotriene B4]] | 9609743 |
| D007975 | Leukotriene B4 | [zileuton results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4 | 11286996|1781415 |
| D007975 | Leukotriene B4 | ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene B4] | 12794006 |
| D007975 | Leukotriene B4 | zileuton inhibits the reaction [ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene B4]] | 12794006 |
| D007975 | Leukotriene B4 | [zileuton results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4 | 9593866 |
| D007975 | Leukotriene B4 | [[A 78773 co-treated with Calcimycin] results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4 | 11529688 |
| D007975 | Leukotriene B4 | ALOX5 protein promotes the reaction [CXCL8 protein results in increased abundance of Leukotriene B4] | 8058773 |
| D007975 | Leukotriene B4 | [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] which results in increased abundance of Leukotriene B4 | 9445378 |
| D007975 | Leukotriene B4 | [[CMI 392 co-treated with Calcimycin] results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4 | 11529688 |
| D007975 | Leukotriene B4 | "[lipopolysaccharide, Escherichia coli O111 B4 results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4" | 12388339 |
| D007975 | Leukotriene B4 | [tepoxalin results in decreased activity of ALOX5 protein] inhibits the reaction [Indomethacin results in increased abundance of Leukotriene B4] | 9223651 |
| D007975 | Leukotriene B4 | "tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4]" | 12388339 |
| D007975 | Leukotriene B4 | [troglitazone results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4 | 10694244 |
| D007975 | Leukotriene B4 | [[zileuton co-treated with Calcimycin] results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4 | 11529688 |
| D007975 | Leukotriene B4 | [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [Calcimycin results in increased abundance of Leukotriene B4] | 18475545 |
| D007975 | Leukotriene B4 | [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [Indomethacin results in increased abundance of Leukotriene B4] | 9223651 |
| D007975 | Leukotriene B4 | [zileuton results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4 | 10694244 |
| D007975 | Leukotriene B4 | ALOX5 protein results in increased chemical synthesis of Leukotriene B4 | 20436887 |
| D007975 | Leukotriene B4 | "[ALOX5 protein results in increased metabolism of 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid] which results in increased abundance of Leukotriene B4 analog" | 7929400 |
| D006632 | Histamine | ALOX5 protein results in increased susceptibility to [Histamine results in increased abundance of Leukotriene B4] | 9609743 |
| D006632 | Histamine | zileuton inhibits the reaction [ALOX5 protein results in increased susceptibility to [Histamine results in increased abundance of Leukotriene B4]] | 9609743 |
| D006861 | Hydrogen Peroxide | ALOX5 protein promotes the reaction [lysophosphatidic acid results in increased abundance of Hydrogen Peroxide] | 10698703 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in increased activity of ALOX5 protein | 10491155 |
| D006861 | Hydrogen Peroxide | [Hydrogen Peroxide results in increased activity of ALOX5 protein] which results in increased chemical synthesis of Leukotriene B4 | 10491155 |
| D006861 | Hydrogen Peroxide | Masoprocol inhibits the reaction [ALOX5 protein promotes the reaction [lysophosphatidic acid results in increased abundance of Hydrogen Peroxide]] | 10698703 |
| D006861 | Hydrogen Peroxide | resveratrol inhibits the reaction [[Hydrogen Peroxide results in increased activity of ALOX5 protein] which results in increased chemical synthesis of Leukotriene B4] | 10491155 |
| D006861 | Hydrogen Peroxide | zileuton inhibits the reaction [ALOX5 protein promotes the reaction [lysophosphatidic acid results in increased abundance of Hydrogen Peroxide]] | 10698703 |
| D006861 | Hydrogen Peroxide | baicalin inhibits the reaction [Hydrogen Peroxide affects the localization of and results in increased activity of ALOX5 protein] | 20139896 |
| D006861 | Hydrogen Peroxide | caffeic acid inhibits the reaction [Hydrogen Peroxide affects the localization of ALOX5 protein] | 18951527 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the localization of ALOX5 protein | 18951527 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the localization of and results in increased activity of ALOX5 protein | 20139896 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide results in decreased activity of ALOX5 protein | 12388339 |
| D006861 | Hydrogen Peroxide | phenylmethylpyrazolone inhibits the reaction [Hydrogen Peroxide affects the localization of ALOX5 protein] | 18951527 |
| D006861 | Hydrogen Peroxide | SB 203580 inhibits the reaction [Hydrogen Peroxide affects the localization of ALOX5 protein] | 18951527 |
| D006861 | Hydrogen Peroxide | [Hydrogen Peroxide co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D006861 | Hydrogen Peroxide | SB 203580 inhibits the reaction [[Hydrogen Peroxide co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein] | 11698504 |
| D006877 | Hydroxamic Acids | Hydroxamic Acids analog results in decreased activity of ALOX5 protein | 7922131 |
| D006893 | Hydroxyeicosatetraenoic Acids | ALOX5 protein results in increased metabolism of Hydroxyeicosatetraenoic Acids metabolite | 11861792 |
| D006893 | Hydroxyeicosatetraenoic Acids | MK-886 inhibits the reaction [ALOX5 protein results in increased metabolism of Hydroxyeicosatetraenoic Acids metabolite] | 11861792 |
| D006918 | Hydroxyurea | Hydroxyurea inhibits the reaction [L 708714 binds to ALOX5 protein] | 7577949 |
| C069794 | ICI 211965 | ICI 211965 results in decreased activity of ALOX5 protein | 8452572 |
| C075799 | ICI D2138 | ICI D2138 results in decreased activity of ALOX5 protein | 7522174|9580604 |
| C075799 | ICI D2138 | ICI D2138 inhibits the reaction [L 708714 binds to ALOX5 protein] | 7577949 |
| C075799 | ICI D2138 | ICI D2138 results in decreased activity of ALOX5 protein | 18475545 |
| C075799 | ICI D2138 | ICI D2138 results in decreased activity of ALOX5 protein | 11509739 |
| D007213 | Indomethacin | Indomethacin results in decreased activity of ALOX5 protein | 3928952 |
| D007213 | Indomethacin | [tepoxalin results in decreased activity of ALOX5 protein] inhibits the reaction [Indomethacin results in increased abundance of Leukotriene B4] | 9223651 |
| D007213 | Indomethacin | [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [Indomethacin results in increased abundance of Leukotriene B4] | 9223651 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of ALOX5 mRNA | 25613284 |
| C402944 | JHW 015 | JHW 015 inhibits the reaction [JUN protein modified form binds to ALOX5 promoter] | 23539630 |
| C402944 | JHW 015 | JHW 015 inhibits the reaction [JUN protein modified form results in increased expression of ALOX5 mRNA] | 23539630 |
| C402944 | JHW 015 | JHW 015 results in decreased expression of ALOX5 mRNA | 23539630 |
| C402944 | JHW 015 | JHW 015 results in decreased expression of ALOX5 protein | 23539630 |
| C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in increased expression of ALOX5 mRNA | 27392435 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of ALOX5 mRNA | 23086925 |
| C006552 | kaempferol | kaempferol inhibits the reaction [ALOX5 protein results in increased chemical synthesis of Leukotriene B4] | 18096136 |
| D007608 | Kainic Acid | Kainic Acid results in increased expression of ALOX5 mRNA | 17139192 |
| C080279 | L 689065 | L 689065 results in decreased activity of ALOX5 protein | 8452572 |
| C096344 | L 708714 | Arachidonic Acid inhibits the reaction [L 708714 binds to ALOX5 protein] | 7577949 |
| C096344 | L 708714 | Calcium promotes the reaction [L 708714 binds to ALOX5 protein] | 7577949 |
| C096344 | L 708714 | Hydroxyurea inhibits the reaction [L 708714 binds to ALOX5 protein] | 7577949 |
| C096344 | L 708714 | ICI D2138 inhibits the reaction [L 708714 binds to ALOX5 protein] | 7577949 |
| C096344 | L 708714 | L 708714 binds to and results in decreased activity of ALOX5 protein | 7577949 |
| C096344 | L 708714 | zileuton inhibits the reaction [L 708714 binds to ALOX5 protein] | 7577949 |
| D017999 | Leukotriene E4 | [zileuton results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene E4 | 10764316|8621850 |
| D017999 | Leukotriene E4 | ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene E4] | 12794006 |
| D017999 | Leukotriene E4 | zileuton inhibits the reaction [ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene E4]] | 12794006 |
| D015289 | Leukotrienes | ALOX5 protein results in increased chemical synthesis of Leukotrienes | 18951527 |
| C433788 | lipopolysaccharide, E. coli O26-B6 | "ALOX5 protein promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased abundance of Leukotriene B4]" | 15501964 |
| C433788 | lipopolysaccharide, E. coli O26-B6 | "zileuton inhibits the reaction [ALOX5 protein promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased abundance of Leukotriene B4]]" | 15501964 |
| C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "lipopolysaccharide, Escherichia coli O111 B4 affects the expression of ALOX5 protein" | 11561080 |
| C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "lipopolysaccharide, Escherichia coli O111 B4 results in decreased activity of ALOX5 protein" | 12388339 |
| C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "[lipopolysaccharide, Escherichia coli O111 B4 results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4" | 12388339 |
| C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4]" | 12388339 |
| C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "zileuton inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased activity of ALOX5 protein]" | 12388339 |
| C440499 | lipopolysaccharide, Escherichia coli O111 B4 | "zileuton inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of ALOX5 protein]" | 11561080 |
| D008070 | Lipopolysaccharides | glucosamine 6-O-sulfate inhibits the reaction [Lipopolysaccharides results in increased expression of ALOX5 mRNA] | 21877189 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of ALOX5 mRNA | 21877189 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased phosphorylation of and results in increased activity of ALOX5 protein | 10779545 |
| D008070 | Lipopolysaccharides | EPHX2 gene mutant form inhibits the reaction [Lipopolysaccharides results in increased expression of ALOX5 protein] | 19896470 |
| D008070 | Lipopolysaccharides | EPHX2 gene mutant form promotes the reaction [MK-886 inhibits the reaction [Lipopolysaccharides results in increased expression of ALOX5 protein]] | 19896470 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of ALOX5 mRNA | 20453108 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of ALOX5 protein | 19896470 |
| D008070 | Lipopolysaccharides | MK-886 inhibits the reaction [Lipopolysaccharides results in increased expression of ALOX5 protein] | 19896470 |
| C040527 | lipoxin A4 | ALOX5 protein affects the abundance of lipoxin A4 | 15326064 |
| C040527 | lipoxin A4 | zileuton inhibits the reaction [ALOX5 protein affects the abundance of lipoxin A4] | 15326064 |
| D017336 | Loratadine | Loratadine analog results in decreased activity of ALOX5 protein | 15482930 |
| D019808 | Losartan | Losartan results in decreased expression of ALOX5 protein | 21377515 |
| D017572 | Leukotriene A4 | ALOX5 protein results in increased chemical synthesis of Leukotriene A4 | 18295198 |
| D017997 | Leukotriene C4 | [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Leukotriene C4] | 9495842 |
| D017997 | Leukotriene C4 | [zileuton results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene C4 | 10764316 |
| D017997 | Leukotriene C4 | ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene C4] | 12794006 |
| D017997 | Leukotriene C4 | zileuton inhibits the reaction [ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene C4]] | 12794006 |
| D017997 | Leukotriene C4 | [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] which results in increased abundance of Leukotriene C4 | 9445378 |
| D017998 | Leukotriene D4 | ALOX5 protein results in increased abundance of Leukotriene D4 | 12629151 |
| D017998 | Leukotriene D4 | [zileuton results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene D4 | 10764316 |
| D017998 | Leukotriene D4 | ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene D4] | 12794006 |
| D017998 | Leukotriene D4 | zileuton inhibits the reaction [ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene D4]] | 12794006 |
| D047311 | Luteolin | Luteolin inhibits the reaction [ALOX5 protein results in increased chemical synthesis of Leukotriene B4] | 18096136 |
| C032881 | lysophosphatidic acid | ALOX5 protein promotes the reaction [lysophosphatidic acid results in increased abundance of Hydrogen Peroxide] | 10698703 |
| C032881 | lysophosphatidic acid | Masoprocol inhibits the reaction [ALOX5 protein promotes the reaction [lysophosphatidic acid results in increased abundance of Hydrogen Peroxide]] | 10698703 |
| C032881 | lysophosphatidic acid | zileuton inhibits the reaction [ALOX5 protein promotes the reaction [lysophosphatidic acid results in increased abundance of Hydrogen Peroxide]] | 10698703 |
| D009637 | Masoprocol | Masoprocol results in decreased activity of ALOX5 protein | 2724698 |
| D009637 | Masoprocol | ALOX5 protein affects the susceptibility to Masoprocol | 19503098 |
| D009637 | Masoprocol | Masoprocol inhibits the reaction [ALOX5 protein promotes the reaction [lysophosphatidic acid results in increased abundance of Hydrogen Peroxide]] | 10698703 |
| D009637 | Masoprocol | Masoprocol results in decreased activity of ALOX5 protein | 10698703|2724698 |
| D009637 | Masoprocol | [Masoprocol results in decreased activity of ALOX5 protein] which results in decreased chemical synthesis of Leukotriene B4 | 2849922 |
| D009637 | Masoprocol | "[Masoprocol results in decreased activity of ALOX5 protein] which results in increased abundance of 15-hydroxy-5,8,11,13-eicosatetraenoic acid" | 2849922 |
| D009637 | Masoprocol | Masoprocol results in decreased activity of ALOX5 protein | 2724698 |
| D009637 | Masoprocol | Masoprocol results in decreased activity of ALOX5 protein | 2724698 |
| D009637 | Masoprocol | Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 mRNA] | 18083043 |
| D009637 | Masoprocol | Masoprocol inhibits the reaction [[CCL5 protein co-treated with Calcimycin] results in increased expression of ALOX5 protein] | 18083043 |
| D009637 | Masoprocol | Masoprocol results in decreased activity of ALOX5 protein | 2724698|3928952 |
| D009637 | Masoprocol | Masoprocol results in decreased activity of ALOX5 protein | 19194550|3145369 |
| C077265 | MCI 826 | MCI 826 results in decreased activity of ALOX5 protein | 2724698 |
| C077265 | MCI 826 | MCI 826 results in decreased activity of ALOX5 protein | 2724698 |
| D008469 | Meclofenamic Acid | Meclofenamic Acid results in decreased activity of ALOX5 protein | 3020588 |
| D008555 | Melitten | Melitten results in increased activity of ALOX5 protein | 18475477 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ALOX5 mRNA | 20938992 |
| D008727 | Methotrexate | ALOX5 protein affects the susceptibility to Methotrexate | 16217747 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of ALOX5 mRNA | 28001369 |
| C060893 | MK-886 | MK-886 results in decreased activity of ALOX5 protein | 8482329 |
| C060893 | MK-886 | MK-886 inhibits the reaction [ALOX5 protein results in increased metabolism of Hydroxyeicosatetraenoic Acids metabolite] | 11861792 |
| C060893 | MK-886 | MK-886 inhibits the reaction [Nicotine results in increased expression of ALOX5 protein] | 20061081 |
| C060893 | MK-886 | EPHX2 gene mutant form promotes the reaction [MK-886 inhibits the reaction [Lipopolysaccharides results in increased expression of ALOX5 protein]] | 19896470 |
| C060893 | MK-886 | MK-886 inhibits the reaction [Lipopolysaccharides results in increased expression of ALOX5 protein] | 19896470 |
| C060893 | MK-886 | MK-886 results in decreased activity of ALOX5 protein | 14726295|9445378 |
| C060893 | MK-886 | MK-886 results in decreased activity of ALOX5 protein | 14569062|2006108 |
| C517284 | monomethyl phthalate | monomethyl phthalate affects the expression of ALOX5 mRNA | 26924002 |
| C093875 | montelukast | ALOX5 gene SNP affects the susceptibility to montelukast | 16293801 |
| C568512 | N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide | "N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide results in decreased activity of ALOX5 protein" | 21899292 |
| C056614 | N-(3-phenoxycinnamyl)acetohydroxamic acid | N-(3-phenoxycinnamyl)acetohydroxamic acid results in decreased activity of ALOX5 protein | 1318347 |
| C056614 | N-(3-phenoxycinnamyl)acetohydroxamic acid | N-(3-phenoxycinnamyl)acetohydroxamic acid results in decreased activity of ALOX5 protein | 21323313|2146616 |
| C056614 | N-(3-phenoxycinnamyl)acetohydroxamic acid | N-(3-phenoxycinnamyl)acetohydroxamic acid results in decreased activity of ALOX5 protein | 11529688 |
| C056614 | N-(3-phenoxycinnamyl)acetohydroxamic acid | N-(3-phenoxycinnamyl)acetohydroxamic acid results in decreased activity of ALOX5 protein | 21341744 |
| C018845 | nafazatrom | nafazatrom results in decreased activity of ALOX5 protein | 3145369 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of ALOX5 mRNA" | 25554681 |
| D009532 | Nickel | Nickel results in increased expression of ALOX5 mRNA | 24768652|2558310 |
| C028007 | nickel monoxide | nickel monoxide results in decreased expression of ALOX5 mRNA | 19167457 |
| D009538 | Nicotine | AG 1879 inhibits the reaction [Nicotine results in increased expression of ALOX5 protein] | 14569062 |
| D009538 | Nicotine | MK-886 inhibits the reaction [Nicotine results in increased expression of ALOX5 protein] | 20061081 |
| D009538 | Nicotine | Nicotine results in increased expression of ALOX5 mRNA | 20061081 |
| D009538 | Nicotine | Nicotine results in increased expression of ALOX5 protein | 14569062|2006108 |
| D009538 | Nicotine | [tyrphostin AG 1478 co-treated with AG 1879] inhibits the reaction [Nicotine results in increased expression of ALOX5 protein] | 14569062 |
| D009538 | Nicotine | tyrphostin AG 1478 inhibits the reaction [Nicotine results in increased expression of ALOX5 protein] | 14569062 |
| D009538 | Nicotine | U 0126 inhibits the reaction [Nicotine results in increased expression of ALOX5 mRNA] | 20061081 |
| D009569 | Nitric Oxide | Nitric Oxide promotes the reaction [Reactive Oxygen Species results in decreased activity of ALOX5 protein] | 12388339 |
| C014707 | nitrosobenzylmethylamine | nitrosobenzylmethylamine results in increased expression of ALOX5 mRNA | 17616710 |
| C025589 | ochratoxin A | ochratoxin A affects the expression of ALOX5 mRNA | 26505656 |
| C025589 | ochratoxin A | ochratoxin A results in decreased expression of ALOX5 mRNA | 26505656 |
| D009822 | Oils, Volatile | "Oils, Volatile results in decreased activity of ALOX5 protein" | 19066064 |
| C484027 | oligofectamine | oligofectamine results in increased expression of ALOX5 mRNA | 14668052 |
| D010047 | Ovalbumin | ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene B4] | 12794006 |
| D010047 | Ovalbumin | ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene C4] | 12794006 |
| D010047 | Ovalbumin | ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene D4] | 12794006 |
| D010047 | Ovalbumin | ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene E4] | 12794006 |
| D010047 | Ovalbumin | Ovalbumin results in increased expression of ALOX5 mRNA | 12794006 |
| D010047 | Ovalbumin | zileuton inhibits the reaction [ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene B4]] | 12794006 |
| D010047 | Ovalbumin | zileuton inhibits the reaction [ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene C4]] | 12794006 |
| D010047 | Ovalbumin | zileuton inhibits the reaction [ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene D4]] | 12794006 |
| D010047 | Ovalbumin | zileuton inhibits the reaction [ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene E4]] | 12794006 |
| D010047 | Ovalbumin | zileuton inhibits the reaction [Ovalbumin results in increased expression of ALOX5 mRNA] | 12794006 |
| C030110 | oxaliplatin | oxaliplatin results in increased expression of ALOX5 mRNA | 25729387 |
| C029341 | oxophenylarsine | [oxophenylarsine co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of ALOX5 mRNA | 26516004 |
| D010100 | Oxygen | caffeic acid inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein] | 18951527 |
| D010100 | Oxygen | [Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein | 18951527 |
| D010100 | Oxygen | phenylmethylpyrazolone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein] | 18951527 |
| D010100 | Oxygen | SB 203580 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein] | 18951527 |
| C046012 | pentanal | pentanal results in increased expression of ALOX5 mRNA | 26079696 |
| D030421 | Peroxynitrous Acid | Peroxynitrous Acid results in decreased activity of ALOX5 protein | 12388339 |
| D030421 | Peroxynitrous Acid | Peroxynitrous Acid results in increased nitrosation of and affects the expression of ALOX5 protein | 11561080 |
| D030421 | Peroxynitrous Acid | zileuton inhibits the reaction [Peroxynitrous Acid results in increased nitrosation of ALOX5 protein] | 11561080 |
| D030421 | Peroxynitrous Acid | Peroxynitrous Acid results in increased nitrosation of ALOX5 protein | 12388339 |
| D030421 | Peroxynitrous Acid | zileuton inhibits the reaction [Peroxynitrous Acid results in increased nitrosation of ALOX5 protein] | 12388339 |
| D010578 | Petroleum | ALOX5 gene SNP affects the susceptibility to Petroleum | 22919386 |
| C015429 | phenidone | phenidone results in decreased activity of ALOX5 protein | 7990266 |
| C015429 | phenidone | phenidone results in decreased activity of ALOX5 protein | 3928952 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [Hydrogen Peroxide affects the localization of ALOX5 protein] | 18951527 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein] | 18951527 |
| D010743 | Phospholipids | Phospholipids results in increased expression of ALOX5 protein | 11937571 |
| C006253 | pirinixic acid | pirinixic acid analog results in decreased activity of ALOX5 protein | 18710209|1905832 |
| D010938 | Plant Oils | Plant Oils results in decreased activity of ALOX5 protein | 19066064 |
| D010972 | Platelet Activating Factor | Platelet Activating Factor results in increased expression of ALOX5 mRNA | 16386258 |
| D010972 | Platelet Activating Factor | [sodium arsenite co-treated with Platelet Activating Factor co-treated with Arachidonic Acid] results in increased phosphorylation of and results in increased activity of ALOX5 protein | 10779545 |
| D010972 | Platelet Activating Factor | [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [Calcimycin results in increased abundance of Platelet Activating Factor] | 8387780 |
| C443641 | poly(propyleneimine) | poly(propyleneimine) analog results in decreased expression of ALOX5 mRNA | 16308212 |
| D011189 | Potassium Chloride | [Potassium Chloride co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in decreased expression of ALOX5 mRNA | 22698814 |
| C005556 | propionaldehyde | propionaldehyde results in increased expression of ALOX5 mRNA | 26079696 |
| D011433 | Propranolol | 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [Propranolol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein]] | 18218859 |
| D011433 | Propranolol | Propranolol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] | 18218859 |
| C513428 | pyrachlostrobin | pyrachlostrobin results in increased expression of ALOX5 mRNA | 27029645 |
| C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [JUN protein modified form binds to ALOX5 promoter] | 23539630 |
| C432165 | pyrazolanthrone | pyrazolanthrone results in decreased expression of ALOX5 protein | 23539630 |
| D011794 | Quercetin | Quercetin inhibits the reaction [ALOX5 protein results in increased chemical synthesis of Leukotriene B4] | 18096136 |
| D011794 | Quercetin | Quercetin results in decreased activity of ALOX5 protein | 3145369 |
| C443401 | quercetin 3-O-glucuronide | quercetin 3-O-glucuronide inhibits the reaction [ALOX5 protein results in increased chemical synthesis of Leukotriene B4] | 18096136 |
| C531389 | quercetin 3'-sulfate | quercetin 3'-sulfate inhibits the reaction [ALOX5 protein results in increased chemical synthesis of Leukotriene B4] | 18096136 |
| D017382 | Reactive Oxygen Species | Nitric Oxide promotes the reaction [Reactive Oxygen Species results in decreased activity of ALOX5 protein] | 12388339 |
| D017382 | Reactive Oxygen Species | Reactive Oxygen Species results in decreased activity of ALOX5 protein | 12388339 |
| C059514 | resveratrol | resveratrol binds to and results in decreased activity of ALOX5 protein | 10491155 |
| C059514 | resveratrol | resveratrol inhibits the reaction [[Hydrogen Peroxide results in increased activity of ALOX5 protein] which results in increased chemical synthesis of Leukotriene B4] | 10491155 |
| C059514 | resveratrol | "resveratrol inhibits the reaction [[OVAL protein co-treated with enterotoxin B, staphylococcal co-treated with Dimethyl Sulfoxide] results in increased expression of ALOX5 protein]" | 23751068 |
| C089730 | rosiglitazone | ALOX5 affects the susceptibility to rosiglitazone | 19321784 |
| C045954 | RS 43179 | RS 43179 results in decreased activity of ALOX5 protein | 2849922 |
| C045954 | RS 43179 | [RS 43179 results in decreased activity of ALOX5 protein] which results in decreased chemical synthesis of Leukotriene B4 | 2849922 |
| C045954 | RS 43179 | "[RS 43179 results in decreased activity of ALOX5 protein] which results in increased abundance of 15-hydroxy-5,8,11,13-eicosatetraenoic acid" | 2849922 |
| C067525 | S(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid | S(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid results in decreased activity of ALOX5 protein | 8482329 |
| C067525 | S(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid | S(alpha)-methyl-6-(2-quinolinylmethoxy)-2-naphthaleneacetic acid results in decreased activity of ALOX5 protein | 8113982 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein] | 10779545 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased phosphorylation of and results in increased activity of ALOX5 protein] | 10779545 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [sodium arsenite results in increased activity of ALOX5 protein] | 10779545 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of ALOX5 protein] | 10779545 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Sorbitol results in increased activity of ALOX5 protein] | 10779545 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of ALOX5 protein] | 10779545 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Thapsigargin results in increased phosphorylation of and results in increased activity of ALOX5 protein] | 10779545 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [TNF protein results in increased phosphorylation of and results in increased activity of ALOX5 protein] | 10779545 |
| C093642 | SB 203580 | SB 203580 results in decreased phosphorylation of and results in decreased activity of ALOX5 protein | 10779545 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of ALOX5 mRNA] | 20382172 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Hydrogen Peroxide affects the localization of ALOX5 protein] | 18951527 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [[Oxygen deficiency co-treated with Glucose deficiency] affects the localization of ALOX5 protein] | 18951527 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [[Hydrogen Peroxide co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein] | 11698504 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [[Sodium Chloride co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein] | 11698504 |
| C115461 | SC 560 | SC 560 promotes the reaction [Carbon Tetrachloride results in increased expression of ALOX5 protein] | 25432964 |
| D012643 | Selenium | [Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 mRNA | 22223226 |
| D012643 | Selenium | [Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 protein | 22223226 |
| C078903 | seocalcitol | seocalcitol results in increased expression of ALOX5 mRNA | 12040012 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of ALOX5 mRNA | 25895662 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of ALOX5 mRNA | 21602193 |
| C017947 | sodium arsenite | SB 203580 inhibits the reaction [sodium arsenite results in increased activity of ALOX5 protein] | 10779545 |
| C017947 | sodium arsenite | SB 203580 inhibits the reaction [sodium arsenite results in increased phosphorylation of and results in increased activity of ALOX5 protein] | 10779545 |
| C017947 | sodium arsenite | [sodium arsenite co-treated with Platelet Activating Factor co-treated with Arachidonic Acid] results in increased phosphorylation of and results in increased activity of ALOX5 protein | 10779545 |
| C017947 | sodium arsenite | sodium arsenite results in increased phosphorylation of and results in increased activity of ALOX5 protein | 10779545 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of ALOX5 mRNA | 25065748 |
| C017947 | sodium arsenite | [sodium arsenite co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| C016104 | sodium bichromate | sodium bichromate results in decreased expression of ALOX5 mRNA | 17685462 |
| D012965 | Sodium Chloride | [AGT protein co-treated with Sodium Chloride] affects the expression of ALOX5 mRNA | 27225954 |
| D012965 | Sodium Chloride | SB 203580 inhibits the reaction [[Sodium Chloride co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein] | 11698504 |
| D012965 | Sodium Chloride | [Sodium Chloride co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D013012 | Sorbitol | SB 203580 inhibits the reaction [Sorbitol results in increased activity of ALOX5 protein] | 10779545 |
| D013012 | Sorbitol | [Sorbitol co-treated with Calcimycin co-treated with Arachidonic Acid] affects the localization of ALOX5 protein | 11698504 |
| D013012 | Sorbitol | Sorbitol results in increased phosphorylation of and results in increased activity of ALOX5 protein | 10779545 |
| D013012 | Sorbitol | [Sorbitol co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D013012 | Sorbitol | [Sorbitol co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D013012 | Sorbitol | Thapsigargin promotes the reaction [[Sorbitol co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein] | 11698504 |
| D013629 | Tamoxifen | Tamoxifen results in increased expression of ALOX5 protein | 9742967 |
| D013629 | Tamoxifen | [Tamoxifen results in increased expression of ALOX5 protein] which results in increased abundance of Leukotriene B4 | 9742967 |
| C062866 | tenidap | tenidap results in decreased activity of ALOX5 protein | 2849922 |
| C062866 | tenidap | [tenidap results in decreased activity of ALOX5 protein] which results in decreased chemical synthesis of Leukotriene B4 | 2849922 |
| C062866 | tenidap | "[tenidap results in decreased activity of ALOX5 protein] which results in increased abundance of 15-hydroxy-5,8,11,13-eicosatetraenoic acid" | 2849922 |
| C073135 | tepoxalin | tepoxalin results in decreased activity of ALOX5 protein | 12629151 |
| C073135 | tepoxalin | tepoxalin results in decreased activity of ALOX5 protein | 9223651 |
| C073135 | tepoxalin | [tepoxalin results in decreased activity of ALOX5 protein] inhibits the reaction [Indomethacin results in increased abundance of Leukotriene B4] | 9223651 |
| D020002 | tert-Butyl Alcohol | tert-Butyl Alcohol inhibits the reaction [Calcimycin results in increased activity of and results in increased localization of ALOX5 protein] | 18218859 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of ALOX5 mRNA | 28487374 |
| D013749 | Tetrachlorodibenzodioxin | AHR mRNA promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of ALOX5 mRNA] | 28487374 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of ALOX5 mRNA | 28487374 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of ALOX5 protein | 28487374 |
| D013755 | Tetradecanoylphorbol Acetate | SB 203580 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of ALOX5 protein] | 10779545 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Calcimycin] affects the localization of ALOX5 protein | 11698504 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased phosphorylation of and results in increased activity of ALOX5 protein | 10779545 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of ALOX5 mRNA | 25613284 |
| C480958 | tetrakis(4-benzoic acid)porphyrin | "tetrakis(4-benzoic acid)porphyrin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4]" | 12388339 |
| D019284 | Thapsigargin | 1-Butanol inhibits the reaction [Thapsigargin results in increased activity of and results in increased localization of ALOX5 protein] | 18218859 |
| D019284 | Thapsigargin | 1-oleoyl-2-acetoyl-sn-glycerol inhibits the reaction [1-Butanol inhibits the reaction [Thapsigargin results in increased activity of and results in increased localization of ALOX5 protein]] | 18218859 |
| D019284 | Thapsigargin | SB 203580 inhibits the reaction [Thapsigargin results in increased phosphorylation of and results in increased activity of ALOX5 protein] | 10779545 |
| D019284 | Thapsigargin | Thapsigargin results in increased activity of and results in increased localization of ALOX5 protein | 18218859 |
| D019284 | Thapsigargin | Thapsigargin results in increased phosphorylation of and results in increased activity of ALOX5 protein | 10779545 |
| D019284 | Thapsigargin | Thapsigargin promotes the reaction [[Sorbitol co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein] | 11698504 |
| D013849 | Thimerosal | Thimerosal results in decreased expression of ALOX5 mRNA | 27188386 |
| C009495 | titanium dioxide | titanium dioxide results in decreased expression of ALOX5 mRNA | 27760801 |
| C009495 | titanium dioxide | titanium dioxide results in increased expression of ALOX5 mRNA | 23409001 |
| D014212 | Tretinoin | Tretinoin results in increased expression of ALOX5 mRNA | 16129123 |
| D014222 | Triamcinolone Acetonide | "Triamcinolone Acetonide inhibits the reaction [[OVAL protein co-treated with enterotoxin B, staphylococcal co-treated with Dimethyl Sulfoxide] results in increased expression of ALOX5 protein]" | 23751068 |
| C015559 | trimellitic anhydride | trimellitic anhydride results in decreased expression of ALOX5 mRNA | 19042947 |
| C057693 | troglitazone | troglitazone results in decreased activity of ALOX5 protein | 10694244|1711357 |
| C057693 | troglitazone | [troglitazone results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4 | 10694244 |
| C101044 | tyrphostin AG 1478 | [tyrphostin AG 1478 co-treated with AG 1879] inhibits the reaction [Nicotine results in increased expression of ALOX5 protein] | 14569062 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Nicotine results in increased expression of ALOX5 protein] | 14569062 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [Acrolein results in increased expression of ALOX5 protein] | 20153347 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Calcimycin results in increased phosphorylation of and results in increased activity of ALOX5 protein] | 10779545 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Nicotine results in increased expression of ALOX5 mRNA] | 20061081 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ALOX5 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of ALOX5 mRNA | 23179753|2438349 |
| D014635 | Valproic Acid | Valproic Acid results in increased methylation of ALOX5 gene | 29154799 |
| D014638 | Vanadates | [Vanadates co-treated with Calcimycin co-treated with Arachidonic Acid] results in increased activity of ALOX5 protein | 11698504 |
| D014810 | Vitamin E | Vitamin E results in decreased activity of ALOX5 protein | 11325678|1220081 |
| D014810 | Vitamin E | [Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 mRNA | 22223226 |
| D014810 | Vitamin E | [Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 protein | 22223226 |
| C063449 | zileuton | zileuton results in decreased activity of ALOX5 protein | 1618819 |
| C063449 | zileuton | zileuton results in decreased activity of ALOX5 protein | 7522174|7644563| |
| C063449 | zileuton | ALOX5 gene SNP affects the susceptibility to zileuton | 19214143 |
| C063449 | zileuton | "zileuton inhibits the reaction [ALOX5 protein promotes the reaction [lipopolysaccharide, E. coli O26-B6 results in increased abundance of Leukotriene B4]]" | 15501964 |
| C063449 | zileuton | zileuton inhibits the reaction [ALOX5 protein promotes the reaction [lysophosphatidic acid results in increased abundance of Hydrogen Peroxide]] | 10698703 |
| C063449 | zileuton | zileuton inhibits the reaction [ALOX5 protein results in increased metabolism of Arachidonic Acid] | 18295198 |
| C063449 | zileuton | zileuton inhibits the reaction [ALOX5 protein results in increased susceptibility to [Histamine results in increased abundance of Leukotriene B4]] | 9609743 |
| C063449 | zileuton | zileuton inhibits the reaction [L 708714 binds to ALOX5 protein] | 7577949 |
| C063449 | zileuton | zileuton results in decreased activity of ALOX5 protein | 10377029|1069870 |
| C063449 | zileuton | [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [Calcimycin results in increased abundance of Platelet Activating Factor] | 8387780 |
| C063449 | zileuton | [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [N-Formylmethionine Leucyl-Phenylalanine results in increased abundance of Leukotriene C4] | 9495842 |
| C063449 | zileuton | [zileuton results in decreased activity of ALOX5 protein] which affects the abundance of Arachidonic Acid | 9495842 |
| C063449 | zileuton | [zileuton results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4 | 11286996|1781415 |
| C063449 | zileuton | [zileuton results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene C4 | 10764316 |
| C063449 | zileuton | [zileuton results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene D4 | 10764316 |
| C063449 | zileuton | [zileuton results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene E4 | 10764316|8621850 |
| C063449 | zileuton | [zileuton results in decreased activity of ALOX5 protein] which results in decreased susceptibility to Arachidonic Acid | 7592874 |
| C063449 | zileuton | zileuton inhibits the reaction [ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene B4]] | 12794006 |
| C063449 | zileuton | zileuton inhibits the reaction [ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene C4]] | 12794006 |
| C063449 | zileuton | zileuton inhibits the reaction [ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene D4]] | 12794006 |
| C063449 | zileuton | zileuton inhibits the reaction [ALOX5 protein promotes the reaction [Ovalbumin results in increased abundance of Leukotriene E4]] | 12794006 |
| C063449 | zileuton | zileuton inhibits the reaction [Ovalbumin results in increased expression of ALOX5 mRNA] | 12794006 |
| C063449 | zileuton | zileuton results in decreased activity of ALOX5 protein | 11694324|1188653 |
| C063449 | zileuton | [zileuton results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4 | 9593866 |
| C063449 | zileuton | [zileuton results in decreased activity of ALOX5 protein] which results in decreased expression of NOS1 | 11694324 |
| C063449 | zileuton | zileuton results in decreased activity of ALOX5 protein | 9831321 |
| C063449 | zileuton | [zileuton results in decreased activity of ALOX5 protein] which results in decreased abundance of Eicosanoids | 9831321 |
| C063449 | zileuton | zileuton binds to and results in decreased activity of ALOX5 protein | 12649539 |
| C063449 | zileuton | [[zileuton co-treated with Calcimycin] results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4 | 11529688 |
| C063449 | zileuton | zileuton inhibits the reaction [ALOX5 protein affects the abundance of lipoxin A4] | 15326064 |
| C063449 | zileuton | zileuton inhibits the reaction [IL13 protein results in increased expression of ALOX5 mRNA] | 12654629 |
| C063449 | zileuton | "zileuton inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased activity of ALOX5 protein]" | 12388339 |
| C063449 | zileuton | "zileuton inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in decreased expression of ALOX5 protein]" | 11561080 |
| C063449 | zileuton | zileuton inhibits the reaction [Peroxynitrous Acid results in increased nitrosation of ALOX5 protein] | 11561080 |
| C063449 | zileuton | zileuton results in decreased activity of ALOX5 protein | 10694244|1472629 |
| C063449 | zileuton | [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [Calcimycin results in increased abundance of Leukotriene B4] | 18475545 |
| C063449 | zileuton | [zileuton results in decreased activity of ALOX5 protein] inhibits the reaction [Indomethacin results in increased abundance of Leukotriene B4] | 9223651 |
| C063449 | zileuton | [zileuton results in decreased activity of ALOX5 protein] which results in decreased abundance of Leukotriene B4 | 10694244 |
| C063449 | zileuton | zileuton results in decreased expression of ALOX5 mRNA | 19309543 |
| C063449 | zileuton | zileuton results in decreased activity of ALOX5 protein | 11509739 |
| C063449 | zileuton | zileuton inhibits the reaction [Peroxynitrous Acid results in increased nitrosation of ALOX5 protein] | 12388339 |
| C063449 | zileuton | zileuton results in decreased activity of ALOX5 protein | 15935457|1667064 |
| D015032 | Zinc | Zinc deficiency results in increased expression of ALOX5 mRNA | 22171008 |
| C088450 | ZM 230487 | ZM 230487 results in decreased activity of ALOX5 protein | 7522174 |
| C088658 | zoledronic acid | zoledronic acid results in increased expression of ALOX5 mRNA | 24714768 |
| D015054 | Zymosan | ALOX5 protein affects the reaction [Zymosan results in increased expression of ICAM1 protein] | 15241586 |
| D015054 | Zymosan | ALOX5 protein affects the reaction [Zymosan results in increased expression of SELP protein] | 15241586 |